Skip to main content
SpringerLink
Log in

Psychopharmacology

  • Chapter
Handbook of Behavior Therapy in the Psychiatric Setting

Part of the book series: Critical Issues in Psychiatry ((CIPS))

  • 712 Accesses

Abstract

This chapter considers how the use of psychotropic medications in hospital settings may influence the activities of behavior therapists in those settings. As the term is used here, psychotropic medications include all drugs that are prescribed with the intent of improving mood, thought processes, or overt behavior. Hospital settings are broadly defined as including all facilities that provide inpatient care for mentally ill, mentally retarded, and dually diagnosed people. Behavior therapists are practitioners who apply procedures based on the principles of experimental psychology to socially significant problems for the purpose of alleviating human suffering and enhancing human functioning (Brown, Wienckowki, & Stolz, 1975). These procedures usually involve operant or respondent conditioning, and their clinical efficacy is characteristically determined empirically, case by case. As the other chapters of this book indicate, the development of effective behavior therapy techniques has provided dramatic benefits for patients with a wide variety of behavior disorders. So, too, has the development of effective psychotropic medications, which have revolutionized psychiatry.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aman, M.N., & Singh, N.N. (1988). Psychopharmacology of the developmental disabilities. New York: Springer-Verlag.

    Book  Google Scholar 

  • American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.; DSM-III-R). Washington, DC: Author.

    Google Scholar 

  • Baldessarini, R.J. (1985a). Chemotherapy in psychiatry. Cambridge: Harvard University Press.

    Google Scholar 

  • Baldessarini, R.J. (1985b). Drugs and the treatment of psychiatric disorders. In A.G. Gilman, L.S. Goodman, T.W. Rall, & F. Murad (Eds.), The pharmacological basis of therapeutics (pp. 387–445). New York: Macmillan.

    Google Scholar 

  • Baldessarini, R.J. (1989) Current status of antidepressants: Clinical pharmacology and therapy. Journal of Clinical Psychiatry, 50, 117–126.

    PubMed  Google Scholar 

  • Bellack, A. (1986) Schizophrenia: Behavior therapy’s forgotten child. Behavior Therapy, 17, 199–214.

    Article  Google Scholar 

  • Benet, L,. Z., & Sheiner, L.W. (1985). Introduction. In A.G. Gilman, L.S. Goodman, T.W. Rall, & F. Murad (Eds.), The pharmacological basis of therapeutics (pp. 1–2). New York: Macmillan.

    Google Scholar 

  • Berger, P.A. (1978) Medical treatment of mental illness. Science, 200, 974–981.

    Article  PubMed  Google Scholar 

  • Birhamer, B., Greenhill, L.L., Cooper, T.B. Fried, J., & Maminski, B. (1989) Sustain released methylphenidate: Pharmacokinetic studies in ADDH males. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 768–772.

    Article  Google Scholar 

  • Borison, R. (1985, May). The recognition and management of drug-induced movement disorders (reversible type). Paper presented at the annual meeting of the American Psychiatric Association, Dallas.

    Google Scholar 

  • Briant, R.H. (1978). An introduction to clinical pharmacology. In J.S. Werry (Ed.), The use of behavior modifying drugs with children (pp. 3–28). New York: Brunner/Mazel.

    Google Scholar 

  • Briggs, R., Garrard, S., Hamad, C., & Wills, F. (1984). A model for evaluating psychoactive medication use with mentally retarded persons. In J.A. Mulick & B.L. Mallory (Eds.), Transitions in mental retardation: Advocacy, technology, and science (pp. 229–248). Norwood, NJ: Ablex.

    Google Scholar 

  • Brown, B.S., Wienckowski, L.A., & Stolz, S.B. (1975). Behavior modification: Perspectives on a current issue. Washington, DC: National Institutes of Mental Health.

    Google Scholar 

  • Cantwell, D.P., & Carlson, G.A. (1978). Stimulants. In J.S. Werry (Ed.), Pediatrie psychopharmacology: The use of behavior modifying drugs with children (pp. 253–301). New York: Brunner/Mazel.

    Google Scholar 

  • Cohen, M.N., & Sprague, R.L. (1977, March). Survey of drug usage in two midwestern institutions for the retarded. Paper presented at the Gatlinburg Conference on Research in Mental Retardation, Gatlinburg, TN.

    Google Scholar 

  • Cramer, J.A., Smith, D.B., Mattson, R.H., Excueta, A.V. D., Collins, J.F., & the VA Cooperative Study Group. (1983). A method of quantification for the evaluation of antiepileptic drug therapy. Neurology, 33 (Suppl. 1), 26–27.

    Article  PubMed  Google Scholar 

  • Engelhardt, D.M. (1974). Withdrawal Emergent Symptoms (WES) Checklist. (Available from author on request, Department of Psychiatry, Downstate Medical Center, State University of New York, 460 Clarkston Ave., Brooklyn, NY 11203.)

    Google Scholar 

  • Fischbacher, E. (1987) Prescribing in a hospital for the mentally retarded. Journal of Mental Deficiency Research, 31, 17–29.

    PubMed  Google Scholar 

  • Gadow, K.D. (1986a). Children on medication: Vol. 1. Hyperactivity, learning disabilities, and mental retardation. San Diego: College-Hill Press.

    Google Scholar 

  • Gadow, K.D. (1986b). Children on medication: Vol. 2. Epilepsy, emotional disturbance, and adolescent disorders. San Diego: College-Hill Press.

    Google Scholar 

  • Gadow, K.D., & Poling, A. (1986). Methodological issues in human psychopharmacology. Greenwich, CT: JAI Press.

    Google Scholar 

  • Gadow, K.D., & Poling, A. (1988). Pharmacotherapy and mental retardation. San Diego: College-Hill Press.

    Google Scholar 

  • Gadow, K.D., White, L., & Ferguson, D.G. (1986a). Placebo controls and double-blind conditions: Part 1. In K.E. Gadow & A. Poling (Eds.), Methodological issues in human psychopharmacology (pp. 41–84). Greenwich, CT: JAI Press.

    Google Scholar 

  • Gadow, K.D., White, L., & Ferguson, D.G. (1986b). Placebo controls and double-blind conditions: Part 2. In K.E. Gadow & A. Poling (Eds.), Methodological issues in human psychopharmacology (pp. 85–114). Greenwich, CT: JAI Press.

    Google Scholar 

  • Gilman, A.G., Goodman, L.S., Rall, T.W., & Murad, F. (1985). The pharmacological basis of therapeutics. New York: Macmillan.

    Google Scholar 

  • Gofman, H. (1972–1973). Interval and final rating sheets on side effects. Psychopharmacology Bulletin (Special Issue), 8–9, 182–187.

    Google Scholar 

  • Gomes-Schwartz, B. (1979) The modification of schizophrenic behavior. Behavior Modification, 3, 439–468.

    Article  Google Scholar 

  • Goth, A. (1984). Medical pharmacology. St. Louis: Mosby.

    Google Scholar 

  • Guy, W. (1976). ECDEU assessment manual for psychopharmacology. Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Hare, E.H., & Wilcox, D.R.C. (1967) Do psychiatric inpatients take their drugs? British Journal of Psychiatry, 113, 1435–1439.

    Article  PubMed  Google Scholar 

  • Hersen, M. (1979) Limitations and problems in the clinical application of behavioral techniques in psychiatric settings. Behavior Therapy, 10, 65–80.

    Article  Google Scholar 

  • Hersen, M. (1986). Pharmacological and behavioral treatment: An integrative approach. New York: Wiley.

    Google Scholar 

  • Hill, B.K., Balow, E.A., & Bruininks, R.H. (1985) A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people. Psychopharmacology Bulletin, 21, 279–284.

    PubMed  Google Scholar 

  • Huessy, H.R., & Ruoff, P.A. (1984) Towards a rational drug usage in a state institution for retarded individuals. Psychiatric Journal of the University of Ottawa, 9, 56–59.

    PubMed  Google Scholar 

  • Julien, R.M. (1985). A primer of drug action. San Francisco: Freeman.

    Google Scholar 

  • Kalachnik, J.E. (1988a). Monitoring of side-effects scale (MOSES). St. Paul: Minnesota Department of Human Services.

    Google Scholar 

  • Kalachnik, J.E. (1988b). Psychotropic medication monitoring checklist and manual for Rule 34 facilities. St. Paul: Minnesota Department of Human Services, Licensing Division.

    Google Scholar 

  • Kane, J.M. (1987). Treatment of schizophrenia. Schizophrenia Bulletin, 13, 133–151.

    Article  Google Scholar 

  • Klein, D.F., Gittelman, R., Quitkin, F., & Rifkin, A. (1980). Diagnosis and drug treatment of psychiatric disorders: Adults and children. Baltimore: Williams & Wilkins.

    Google Scholar 

  • La Mendola, W., Zaharia, E., & Carver, M. (1980) Reducing psychotropic drug use in an institution for the retarded. Hospital and Community Psychiatry, 31, 272–272.

    Google Scholar 

  • Laska, E., Varga, E., Wanderling, J., Simpson, G., Logemann, G.W., & Shah, B.K. (1973) Patterns of psychotropic drug use for schizophrenia. Diseases of the Nervous System, 34, 294–305.

    PubMed  Google Scholar 

  • Laska, E., Craig, T.J., Siegel, C., & Wanderling, J. (1981). Long-term monitoring of psychopharmacological treatment in hospitalized patients. In G. Tognoni, C. Belantuono, & M. Lader (Eds.), Epidemiological impact of psychotropic drugs (pp. 101–116). New York: Elsevier.

    Google Scholar 

  • Longo, V.G. (1972). Neuropharmacology and behavior. San Francisco: Freeman.

    Google Scholar 

  • Marholin, D., Touchette, P.E., & Stewart, R.M. (1979) Withdrawal of chronic chlorpromazine medication: An experimental analysis. Journal of Applied Behavior Analysis, 12, 150–171.

    Article  Google Scholar 

  • National Institute of Mental Health. (1985a) AIMS (Abnormal Involuntary Movement Scale). Psychopharmacology Bulletin, 20, 1077–1080.

    Google Scholar 

  • National Institute of Mental Health. (1985b) DOTES (Dosage Record and Treatment Emergent Symptom Scale). Psychopharmacology Bulletin, 20, 1067–1068.

    Google Scholar 

  • National Institute of Mental Health. (1985c) STRESS (Subjective Treatment Emergent Symptoms Scale). Psychopharmacology Bulletin, 20, 1073–1075.

    Google Scholar 

  • National Institute of Mental Health. (1986) Systematic Assessment for Treatment Emergent Events (SAFTEE). Psychopharmacology Bulletin, 22, 347–381.

    Google Scholar 

  • O’Brien, M., & Orbzut, J. (1986) Attention deficit disorder with hyperactivity: A review and implications for the classroom. The Journal of Special Education, 20, 281–297.

    Article  Google Scholar 

  • O’Leary, D.K. (1980) Pills or skills for hyperactive children? Journal of Applied Behavior Analysis, 13, 191–204.

    Article  PubMed  Google Scholar 

  • Pelham, W.E., Jr., & Murpy, H.A. (1986). Attention deficit and conduct disorders. In M. Hersen (Ed.), Pharmacological and behavioral treatment: An integrative approach (pp. 108–148). New York: Wiley.

    Google Scholar 

  • Poling, A., Gadow, K., & Cleary, J. (1991). Drug therapy for behavior disorders: An introduction. New York: Pergamon Press.

    Google Scholar 

  • Prien, R.F., Haber, P.A., & Caffey, E.M. (1975) The use of psychoactive drugs in elderly patients with psychiatric disorders: Survey conducted in twelve Veterans Administration hospitals. Journal of the American Geriatric Society, 23, 104–112.

    Google Scholar 

  • Prien, R.F., Klett, C.J., & Caffey, E.M. (1976) Polypharmacy in the psychiatric treatment of elderly hospitalized patients: A survey of 12 Veterans Administration hospitals. Diseases of the Nervous System, 37, 333–336.

    Google Scholar 

  • Pulman, R.M., Pook, R.B., & Singh, N.N. (1979) Prevalence of drug therapy for institutionalized mentally retarded children. Australian Journal of Mental Retardation, 5, 212–214.

    Google Scholar 

  • Ross, D.M., & Ross, S.A. (1982). Hyperactivity: Current issues, research, and theory. New York: Wiley.

    Google Scholar 

  • Scandinavian Society of Psychopharmacology Committee of Clinical Investigations (UKU). (1987). The UKU side effects rating scale. Acta Psychiatrica Scandinavica, 76 (entire supplement).

    Google Scholar 

  • Sewell, J., & Werry, J.S. (1976) Some studies in an institution for the mentally retarded. New Zealand Medical Journal, 84, 317–319.

    PubMed  Google Scholar 

  • Sheppard, C., Collins, L., Fiorentino, D., Fracchia, J., & Merlis, S. (1969) Polypharmacy in psychiatric treatment: 1. Incidence at a state hospital. Current Therapeutic Research, 11, 114–765.

    Google Scholar 

  • Silva, D.A. (1979) The use of medication in a residential institution for mentally retarded persons. Mental Retardation, 17, 285–288.

    PubMed  Google Scholar 

  • Simpson, G.M., & Angus, J.W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica (Suppl. 212), 11–19.

    Article  PubMed  Google Scholar 

  • Simpson, G.M., Lee, J.H., Zoubok, B., & Gardos, G. (1979) A rating scale for tardive dyskinesia. Psychopharmacology, 64, 171–179.

    Article  PubMed  Google Scholar 

  • Smith, R.C., Allen, R., Gordon, J., & Wolff, J. (1983) A rating scale for tardive dyskinesia and parkinsonian symptoms. Psychopharmacology Bulletin, 19, 266–276.

    PubMed  Google Scholar 

  • Sneader, W. (1986). Drug discovery: The evolution of modern medicines. New York: Wiley.

    Google Scholar 

  • Spencer, D.A. (1974) A survey of the medication in a hospital for the mentally handicapped. British Journal of Psychiatry, 124, 507–508.

    Article  PubMed  Google Scholar 

  • Sprague, R.L., & Werry, J.S. (1971). Methodology of psychopharmacological studies with the retarded. In N.R. Ellis (Ed.), International review of research in mental retardation (Vol. 5, pp. 147–219). Orlando, FL: Academic Press.

    Google Scholar 

  • Sprague, R.L., White, D.M., Ullmann, R., & Kalachnik, J.E. (1984) Methods for selecting items in a tardive dyskinesia rating scale. Psychopharmacology Bulletin, 20, 339–345.

    PubMed  Google Scholar 

  • Sprague, R.L., Kalachnik, J.E., & White, D.M. (1985). Dyskinesia Identification System: Condensed User Scale (DISCUS). Champaign, IL: Institute for Child Behavior and Development.

    Google Scholar 

  • TU, J.B. (1979) A survey of psychotropic medication in mental retardation facilities. Journal of Clinical Psychiatry, 40, 125–128.

    PubMed  Google Scholar 

  • Usdin, E., & Efron, D.H. (1972). Psychotropic drugs and related compounds. Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Wallace, C.J., Donahoe, C.P., Jr., & Boone, S.E. (1986). Schizophrenia. In M. Hersen (Ed.), Pharmacological and behavioral treatment: An integrative approach (pp. 357–381). New York: Wiley.

    Google Scholar 

  • Werry, J.S. (1978). Pediatric psychopharmacology: The use of behavior modifying drugs with children. New York: Brunner/Mazel.

    Google Scholar 

  • White, A.J. (1983) Changing patterns of psychoactive drug use with the mentally retarded. New Zealand Medical Journal, 96, 686–688.

    PubMed  Google Scholar 

  • Wysowski, D.K., & Baum, C. (1989) Antipsychotic drug use in the United States, 1976–1985. Archives of General Psychiatry, 46, 929–932.

    Article  PubMed  Google Scholar 

  • Zimbardo, P.G. (1988). Psychology and life. Glenview, IL: Scott, Foresman.

    Google Scholar 

  • Zimmermann, R.L., & Heistad, G.T. (1982) Studies of the long term efficacy of antipsychotic drugs in controlling the behavior of institutionalized retardates. Journal of the American Academy of Child Psychiatry, 21, 136–143.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, Western Michigan University, Kalamazoo, Michigan, 49008, USA

    Alan Poling & A. Lynn Bradshaw

Authors
  1. Alan Poling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lynn Bradshaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical College of Pennsylvania at EPPI, Philadelphia, Pennsylvania, USA

    Alan S. Bellack Ph.D.

  2. School of Psychology, Nova University, Fort Lauderdale, Florida, USA

    Michel Hersen Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Poling, A., Bradshaw, A.L. (1993). Psychopharmacology. In: Bellack, A.S., Hersen, M. (eds) Handbook of Behavior Therapy in the Psychiatric Setting. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2430-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2430-8_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2432-2

  • Online ISBN: 978-1-4899-2430-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation